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Abstract
Background
Postural instability and gait disability threaten the independence and well-being of people
with Parkinson’s disease and increase the risk of falls and fall-related injuries. Prospective
research has shown that commonly-used clinical assessments of balance and walking lack
the sensitivity to accurately and consistently identify those people with Parkinson’s disease
who are at a higher risk of falling. Wearable sensors provide a portable and affordable alter-
native for researchers and clinicians who are seeking to objectively assess movements and
falls risk in the clinical setting. However, no consensus currently exists on the optimal place-
ments for sensors and the best outcome measures to use for assessing standing balance
and walking stability in Parkinson’s disease patients. Hence, this systematic review aimed
to examine the available literature to establish the best sensor types, locations and out-
comes to assess standing balance and walking stability in this population.
Methods
Papers listed in three electronic databases were searched by title and abstract to identify
articles measuring standing balance or walking stability with any kind of wearable sensor
among adults diagnosed with PD. To be eligible for inclusion, papers were required to be
full-text articles published in English between January 1994 and December 2014 that as-
sessed measures of standing balance or walking stability with wearable sensors in people
with PD. Articles were excluded if they; i) did not use any form of wearable sensor to mea-
sure variables associated with standing balance or walking stability; ii) did not include a
control group or control condition; iii) were an abstract and/or included in the proceedings
of a conference; or iv) were a review article or case study. The targeted search of the three
electronic databases identified 340 articles that were potentially eligible for inclusion, but
following title, abstract and full-text review only 26 articles were deemed to meet the inclu-
sion criteria. Included articles were assessed for methodological quality and relevant data
from the papers were extracted and synthesized.
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Results
Quality assessment of these included articles indicated that 31% were of low methodologi-
cal quality, while 58% were of moderate methodological quality and 11% were of high meth-
odological quality. All studies adopted a cross-sectional design and used a variety of sensor
types and outcome measures to assess standing balance or walking stability in people with
Parkinson’s disease. Despite the typically low to moderate methodological quality, 81% of
the studies reported differences in sensor-based measures of standing balance or walking
stability between different groups of Parkinson’s disease patients and/or healthy controls.
Conclusion
These data support the use of wearable sensors for detecting differences in standing balance
and walking stability between people with PD and controls. Further high-quality research is
needed to better understand the utility of wearable sensors for the early identification of Par-
kinson’s disease symptoms and for assessing falls risk in this population.
PROSPERO Registration
CRD42014010838
Introduction
Parkinson’s disease (PD) is an age-related neurodegenerative disorder that results from the loss
of neurons within the basal ganglia that produce dopamine, an important neurotransmitter in-
volved in the regulation of movement. As medical advances have extended the life expectancy of
the average person, clinical and experimental methods need to progress as well in order to im-
prove the management of the symptoms associated with the disease. It is well understood that
deficits in balance and gait are common and disabling features of PD that significantly increase
an individual’s risk of falling [1]. Subsequently, many clinical assessments have been developed
to evaluate these symptoms in this population. The most common assessments include the Berg
Balance Scale [2, 3], the Tinetti Gait and Balance assessment [2], the Timed up and Go test [2,
4] and the postural instability and gait disability (PIGD) score derived from the Unified Parkin-
son’s Disease Rating Scale (UPDRS) [2, 5]. These assessments are suited to clinical settings be-
cause they require little equipment to conduct and provide almost immediate outcomes that can
be reported to the patient. However, prospective research shows these tests have poor sensitivity
and specificity for identifying prospective fallers in the PD population [2] and may not be suffi-
ciently sensitive to detect changes in balance and walking in people with PD who have mild to
moderate disease severity [6–9].
Given the inherent short-comings of the aforementioned clinical tests, previous research
has sought to improve the objectivity of these measures to enhance their ability to track symp-
tom progression and evaluate patient risk. Camera-based three-dimensional motion analysis
systems have been commonly used in laboratory settings to examine the walking patterns of
people with PD [10–12]. However, the methods associated with these assessments are often
time-consuming and require specific expertise and expensive motion capture systems that are
impractical for smaller clinical spaces. Wearable sensors, such as accelerometers or inertial
measurement units (IMUs), offer a more portable, flexible and moderately-priced alternative
to camera-based motion analysis systems. Moreover, wearable sensors do not require excessive
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space for normal operation and outcome measures can be output almost immediately without
the need for significant post-processing procedures. Given these strengths, research has recent-
ly sought to improve the sensitivity of clinical assessments, such as the Timed Up and Go test,
by incorporating accelerometers or IMUs to provide continuous measures of walking [13–17].
The results of this research demonstrated that it was possible to detect differences in the perfor-
mances of people with PD compared with controls by instrumenting the Timed Up and Go
test with a wearable sensor [13–17].
Wearable sensors have recently shown good test-retest reliability for assessing individuals
with PD, particularly for acceleration-based measures calculated in the time domain (e.g. jerk;
the first time derivative of acceleration) [13]. Furthermore, a growing body of literature sup-
ports the use of wearable sensors to assess standing balance or walking for; i) people with PD
and controls [13, 14, 18–29]; ii) PD fallers and non-fallers [30, 31]; iii) people with different PD
sub-types [17, 32–35]; iv) carriers and non-carriers of the LRRK2 gene [36]; and v) people at
high risk of developing PD (HRPD) [37, 38]. Results from these studies demonstrate that out-
comes derived from wearable sensors are effective for detecting differences in standing balance
between HRPD patients, people with PD and controls [38]. When combined in a logistic re-
gression model, it was evident that outcome measures derived from wearable sensors can dis-
criminate HRPD patients from controls using an instrumented functional reach test [37].
Furthermore, three-dimensional accelerometers positioned on the head, trunk or pelvis, have
highlighted less rhythmic walking patterns for people with PD who retrospectively reported
falling than patients without falls [30, 31]. Collectively, these results suggest that wearable sen-
sors may not only be useful for evaluating changes in a patient’s balance or gait patterns, but
may also offer a means of screening individuals for various risk factors associated with PD or
falls. Nevertheless, scientifically-rigorous prospective research is needed before stronger recom-
mendations can be provided regarding the use of these devices as predictive instruments for
clinical populations.
Despite the expanding body of evidence to support the use of wearable sensors for assessing
function in people with PD, it is important to recognise that this area of science is still develop-
ing. Furthermore, the adoption of such varying methodological approaches in the existing litera-
ture makes it difficult to determine which type of sensor is the best to use and which placements
and outcome measures are optimal to maximise the utility of these devices. As such, it was the
purpose of this systematic review to examine the available literature that utilised wearable sen-
sors to measure standing and walking balance in people with PD and provide a summary of the
best sensor types, locations and outcomes based on a consensus of the literature.
Methods
This review was registered with the International Prospective Register of Systematic Re-
views on September 3, 2014 (PROSPERO Registration: CRD42014010838). The search
strategy and study protocol are available at http://www.crd.york.ac.uk/PROSPEROFILES/
10838_STRATEGY_20141106.pdf.
Search Strategy
An electronic database search of titles and abstracts was performed in January 2015 using PubMed,
EMBASE and the Cochrane Library to identify articles measuring standing balance and walking
stability with any kind of wearable sensor among adults diagnosed with PD. The following terms
were used for the literature search: ‘Parkinson’, ‘Parkinson’s’, ‘walk’, ‘gait’, ‘balance’, ‘stability’, ‘sen-
sor’, ‘gyroscope’, ‘inertial’, ‘acceleration’ and ‘accelerometer’. Specifically, papers that were included
in this review were required to have the term ‘Parkinson or Parkinson’s’AND (‘walk’OR ‘gait’OR
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‘balance’OR ‘stability’) AND (‘sensor’OR ‘gyroscope’OR ‘inertial’OR ‘accelerometer’OR ‘acceler-
ation’) located within the title and/or abstract. In addition to the systematic electronic database
search, a targeted search of the bibliographies of relevant articles was also performed to identify
any additional studies for inclusion. The research protocol for this systematic review is included as
Supporting Information and outlines the procedures followed and the exact search strategy used
for this study (S1 File).
Selection Criteria
Only original, full-text articles published in English between January 1994 and December 2014
that assessed standing balance or walking stability with wearable sensors in people with PD
were included in this review. Articles were excluded if they; i) did not use any form of wearable
sensor to measure variables associated with standing balance or walking stability; ii) did not in-
clude a control group or control condition; iii) were an abstract and/or included in the proceed-
ings of a conference; or iv) were a review article or case study. All studies that met the inclusion
criteria were considered for review, irrespective of their research design (cross-sectional, rando-
mised controlled trial, etc). After the initial literature search was completed, two assessors
(RPH, MHC) independently screened each of the papers based on their title and abstract and
made a decision on the suitability of the paper for inclusion in the review. Once both reviewers
had completed this process, any and all discrepancies between the two assessments were dis-
cussed until a consensus was reached regarding each paper. Full-text articles were retrieved for
all of the papers selected for inclusion based on the title and abstract review process and the
full-text of these articles was reviewed for suitability by one assessor (RPH). A flow diagram il-
lustrating the study selection process is provided in Fig 1.
Data Extraction and Quality Assessment
Upon selection of the articles for inclusion, one assessor (RPH) extracted and collated infor-
mation concerning the type and number of participants, their mean age, disease duration and
symptom severity, as well as the type and location of the wearable sensor(s) used and the major
findings of each study (Table 1). The included studies presented a range of outcomes that sought
to gain a better insight into the deficits of standing balance and walking stability evident in peo-
ple with PD and these included; i) the root mean square (RMS) of segmental accelerations; ii)
the harmonic ratio; iii) jerk (the first derivative of acceleration); iv) step or stride variability; v)
step or stride regularity/symmetry; and vi) other less commonly-used measures of stability.
In addition to extracting and compiling these data, a quality assessment was performed by
using a modified version of a previously-developed 27-item quality checklist, designed to ac-
commodate both randomised and non-randomised studies [14]. To evaluate the overall meth-
odological quality of each paper, 25 of the criteria on the quality assessment tool were assigned
a score of one point if the criterion was met or a zero if the criterion was not met. If it was not
possible or unreasonably difficult for the assessors to determine whether the information re-
quired for a particular criterion had been provided by the authors, a score of zero was given for
that criterion. Of the remaining two questions on the quality checklist, one question evaluating
whether potentially confounding variables had been reported by the authors was assessed on a
2-point scale, where the study was given 2 points if confounders were clearly described, 1 point
if they were partially described or 0 points if they were not described. The final methodological
aspect of the studies that was evaluated was statistical power, which was more heavily weighted
than the other criteria and assessed on a 5-point scale. Studies that achieved a statistical power
of70% for the standing balance or walking stability measures were given a score of zero,
while those that achieved powers of 80, 85, 90, 95 or 99% were assigned scores of 1 to 5,
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respectively. Where an appropriate statistical power calculation was not provided by the au-
thors, it was necessary to evaluate the statistical power of each study based on the data pre-
sented by the authors. If a statistical power calculation was not reported and the raw data were
not presented, the paper was given a score of zero for this criterion. After each paper was as-
sessed against these criteria, the scores were summed and divided by the maximum total points
to yield a final score that represented the percentage of total possible points earned. This per-
centage score was used to evaluate the overall quality of the study using quartiles to classify the
methodological quality of the article as either very low (25%), low (>25%, but50%), mod-
erate (>50%, but75%) or high (>75%). The methodological quality assessment tool (S2 File)
and the scoring of each of the studies included in this review (Table A in S2 File) are provided
as Supporting Information.
Results
The initial database search identified 335 articles that were potentially eligible for inclusion in
this review. Of the 335 studies identified, 98 were excluded as duplicates, 114 were conference
abstracts, six were review articles and six were written in a language other than English. The
remaining 115 papers were screened by title and abstract, which resulted in 34 being excluded,
based on title and 38 being excluded based on abstract. A manual search was conducted of
the bibliographies of those papers that were considered appropriate for full-text review, which
Fig 1. Flow diagram outlining the progression of the study’s systematic search strategy and review
process, which led to the identification of the articles included in the review.
doi:10.1371/journal.pone.0123705.g001
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identified five additional papers for consideration. Following full-text review of the remaining
44 studies, a further 18 studies were excluded, including one that was unattainable, three that
had no control group or condition and 14 that had no sensor-based measure of standing bal-
ance or walking stability. The remaining 26 articles were selected for inclusion in this system-
atic review.
Study Design and Methodological Quality
All 26 studies included within this review had a cross-sectional research design with a broad
aim of using different types of wearable sensors to observe or identify differences in standing
balance or walking stability for Parkinson’s disease compared with controls or a control condi-
tion (e.g. on medication vs. off medication, PD subtypes). Given their cross-sectional nature,
ten items were excluded from the methodological quality checklist, as they specifically targeted
qualities that are unique to intervention studies. The decision to exclude these criteria was
made to ensure that the overall quality of the studies included in this review was not unfairly
biased by these items that were not relevant to their chosen design.
Based on the appraisal of methodology quality, eight papers were identified as being of low
methodological quality (range = 31.8% to 50.0%), 15 papers were of moderate methodological
quality (range = 54.5% to 72.7%) and three papers were of high methodological quality
(range = 77.3% to 90.9%). In general, the reviewed papers performed poorly on criteria ad-
dressing external validity (e.g. representativeness of the sample), internal validity (e.g. identifi-
cation of and adjustment for potential confounders) and statistical power (e.g. no power
calculation and insufficient details to make an informed appraisal).
Sensor Type and Placement
Multiple wearable sensor types were used within the included articles to assess measures of
standing balance and walking stability. Of these studies, 69% reported using three-dimensional
accelerometers [14, 17–23, 30–37, 39, 40], 27% used inertial sensors [13, 24–28, 38], and 4%
used other types of sensors [28, 29]. Similarly, there were multiple protocols described with re-
spect to the placement of the wearable sensors on the human body. Of the 26 included studies,
85% reported placing a wearable sensor on either the lumbar or sacral region of the trunk [13,
14, 17–22, 24–27, 31–40] and 15% reported placing devices on other body landmarks (e.g.
head, shank, wrist) [23, 28–30]. Details on the studies included in this review that reported
using each specific type and placement of sensors are summarised in Table 1.
Assessment of standing balance and walking stability
Of the 26 included studies, 65% used wearable sensors to assess walking during clinical tests,
such as the Timed up and Go Test [14, 28] or during assessments of straight-line walking at a
self-selected speed [17–23, 27, 29–31, 34–36, 39]. A wide range of sampling frequencies was
used to assess walking stability in the reviewed studies, with authors reporting sampling fre-
quencies ranging between 20 and 1024 Hz. The remaining nine studies (35%) assessed standing
balance using an instrumented functional reach test [37], dynamic posturography [24] or one
of many pre-existing clinical tests conducted during quiet stance (i.e. the Romberg test, tandem
stance, semi-tandem stance, standing with eyes open and eyes closed) [13, 25, 26, 32, 33, 38,
40]. Understandably, the wearable sensors used in these studies were generally set to collect
data at a slower rate to those used for assessing the dynamic tasks, with reported sampling fre-
quencies ranging from 50 to 128 Hz.
The included studies reported multiple outcomes of standing balance and walking stability
that were calculated from the signals provided by the wearable sensors (e.g. accelerations). Of
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these outcomes, the most commonly-reported measures of standing balance included postural
sway velocity (23% of studies) [13, 25, 26, 32, 33, 38], RMS accelerations (19% of studies) [13,
24–26, 38] and jerk (19% of studies) [13, 25, 26, 37, 38]. The most commonly-reported mea-
sures of walking stability included, the harmonic ratio (31% of studies) [14, 17, 19, 20, 22, 30,
35, 39] and stride timing variability (27% of studies) [17, 19, 22, 28–30, 36]. A summary of the
studies reporting each of the outcome measures of standing balance and walking stability is
provided in Table 2.
Discussion
The purpose of this systematic review was to examine the existing literature to determine the
best types of wearable sensors and the most appropriate anatomical placements and outcome
measures to assess deficits in balance and gait between people with PD and controls. Using the
methodological quality assessment tool adapted from Downs and Black [41], it was determined
that the overall quality of scientific reporting in this area is largely of low to moderate quality.
In general, the reviewed papers were lacking details concerning the representativeness of the
study population (external validity), the approaches adopted to identify and account for con-
founding variables (internal validity) and an appropriate justification for the chosen sample
size. Interestingly, 62% of the included studies received a score of zero for all of the criteria re-
lated to at least two of these three areas, while one study (4%) received a score of zero for all
three of these areas. The heavier weighting attributed to the sample size criterion is indicative
of the importance of ensuring that a study has sufficient statistical power to identify a differ-
ence where one exists and, hence, minimise the likelihood of incorrectly accepting the null hy-
pothesis (i.e. Type II error) [42]. Of the 26 studies included in this review, not one reported the
results of a sample size calculation, but 13 (50%) had fewer than 15 participants in each of their
groups [13, 19–21, 23–28, 32, 34, 39] and three others (12%) had at least one group with fewer
than this number [29, 37, 38]. While it is important to emphasise that a large sample size is not
always required to address a specific research question, reporting the outcome of an appropri-
ate a-priori statistical power calculation is beneficial for determining the overall rigor of the
reported findings.
Of the other methodological aspects that were poorly reported, the lack of appropriate detail
regarding the influence of confounding variables was quite substantial, as failure to account for
these factors may result in a study observing a significant change that is simply the manifestation
of another variable not adequately controlled for [43]. For example, it is widely recognised that
gait and balance variables are influenced by walking speed [44–48] and age [49–51], hence if
groups differ for either or both of these variables, appropriate adjustments should be made to ac-
count for this. Of the reviewed studies, 15 (58%) described the principal confounder(s) of their re-
search and reported having made adjustments to their outcomes to account for these variable(s)
[17, 19, 22, 26–32, 35, 36, 38–40]. Of the remaining studies, four (15%) provided a description of
the potential confounders, but lacked clear descriptions of how they were accounted for in their
analyses [14, 21, 34, 37], while seven (27%) neither reported nor accounted for their potential con-
founders [13, 18, 20, 23–25, 33]. In the study by Fazio et al [18], it was reported that people with
PD had significantly lower accelerations and jerk scores than ataxic patients and healthy controls.
However, the age of the patients in the PD group (n = 17) ranged from 60–85 years, while the
ataxic patients (n = 24) and controls (n = 24) were aged between 20 and 85 years, with more than
60% of these participants aged less than 60 years. Furthermore, the authors reported that the PD
and ataxic patients walked significantly slower than the control participants. Given the differences
in age and walking speed between the cohorts, it is difficult to determine whether the reported dif-
ferences in acceleration profiles were indicative of disease-related changes or whether they were
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Table 2. Summarises and defines the sensor-basedmeasures of standing balance and walking stability used in the studies included in this
review.
Outcome Measure Deﬁnition of Measure Articles
Standing Balance or
Walking Stability
Mean acceleration The average of the anteroposterior (AP), mediolateral (ML) or vertical (VT) accelerations during
a speciﬁc phase of the movement. Provides an indication of the rate of change in the velocity of
the body during this phase. Under static conditions, larger values would represent poorer
control.
[37]
Root mean square (RMS)
acceleration
Taking the RMS of the accelerations makes all values of the time series positive, to yield an
average positive amplitude for AP, ML or VT accelerations. Like mean accelerations, RMS
accelerations provides an indication of the rate of change in velocity, but is more robust for data
that has both positive and negative values.
[13,14,18,24–26,30,38]
Jerk Time series of the ﬁrst derivative of acceleration (third derivative of displacement), representing
the rate of change of acceleration. It is calculated from the raw AP, ML or VT accelerations.
During steady movements, the body should be neither accelerating nor decelerating rapidly,
hence Jerk scores should be smaller for more stable people.
[13,25,26,37,38]
Root mean square (RMS)
Jerk
Similar to RMS accelerations, RMS Jerk mathematically converts all values to a positive number
and provides an average value for the AP, ML and VT Jerk time series. In lay terms, the RMS
Jerk provides a single value that describes the jerkiness of the movement.
[18]
Normalised Jerk RMS Jerk score divided by overall movement time. Provides similar information to RMS Jerk,
but takes into account differences in task duration for different populations.
[14]
Standing Balance
Maximum sway distance The resultant of AP and ML displacement is calculated for an inertial measurement unit placed
at the height of the centre of mass (COM; 55% of height). Maximum sway distance is the single
largest value recorded throughout the trial. Provides insight into the extremes of postural sway.
[32]
Mean sway distance The resultant of AP and ML displacement is calculated for an inertial measurement unit placed
at the height of the COM (55% of height). Mean sway distance is the average of all resultant
values recorded throughout the trial. Larger values represent poorer postural control.
[13,32]
Sway Range The overall range of displacement of the centre of mass (COM; estimated from an inertial
measurement unit positioned on the trunk) in the anteroposterior (AP) and mediolateral (ML)
directions. Larger values represent an increased amount of postural sway.
[40]
Length of sway The total distance travelled by the COM on the transverse plane. Increased length of sway
indicates more sway per unit of time and, hence, reduced postural control.
[13,32,33]
Mean sway velocity The ﬁrst integral of the AP, ML or VT acceleration signals. Higher sway velocities represent
more erratic postural adjustments and, hence, poorer postural control.
[13,25,26,33,38]
Sway area The elliptical area that encapsulates the sway path derived from the AP and ML accelerations.
Larger sway areas represent an increased volume of sway, which may suggest poorer balance.
[13]
F95 The frequency below which 95% of the acceleration signals power is present. Higher
frequencies would represent a larger number of postural adjustments to maintain balance during
the trial.
[13,25,26,38]
Centroidal frequency The frequency at which the power of the signal above and below are exactly balanced (i.e. the
centre point). The centroidal frequency can be calculated for the AP, ML and VT axes
separately. Lower frequencies represent poorer postural control.
[33]
High frequency power Percentage of the acceleration signal that is present between 4 and 7 Hz. A greater proportion
of data in this high frequency band represents increased postural adjustment and postural sway.
[40]
Frequency dispersion A unitless frequency-based measure of variability. Values closer to zero would represent more
regular patterns of sway, while values closer 1 represent a greater degree of variability.
[40]
Walking Stability
Harmonic Ratio A measure of the stability of gait-related accelerations by evaluating the stride-to-stride
regularity of the harmonics within the acceleration signal. Walking patterns that produce higher
ratios have more regular acceleration proﬁles over successive gait cycles (i.e. less stride-to-
stride variability); hence, the gait pattern is deemed to be more stable.
[14,17,19,20,30,31,
35,39]
Step and stride regularity The regularity of the AP, ML or VT acceleration proﬁles from step-to-step or stride-to-stride.
Higher regularity scores represent a more rhythmic and consistent walking pattern and is often
said to reﬂect a more stable gait pattern.
[17,23,31,35,36]
Step symmetry Ratio of step regularity to stride regularity. A ratio closer to 1 represents greater symmetry
between the left and right steps, while values closer to 0 indicate poorer symmetry.
[23]
(Continued)
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simply representative of age-related and/or speed-related factors. Identifying all potential con-
founders in this type of research and reporting how they have been accounted for in the analyses
is critical to ensuring that any changes in outcome can be confidently attributed to the treatment
or disease of interest. Collectively, the results of the methodological quality assessment identified
Table 2. (Continued)
Outcome Measure Deﬁnition of Measure Articles
Step and stride timing
variability
The standard deviation (SD) or the coefﬁcient of variation ((SD/mean)*100) of all step or stride
times collected during a trial. Greater variability represents a less rhythmic walking pattern that
is often said o reﬂect a less stable gait pattern.
[17,19,22,28–30,36]
Stride length variability The standard deviation (SD) or the coefﬁcient of variation ((SD/mean)*100) of all stride lengths
collected for the left and right leg collected throughout a trial. Greater variability represents a
less predictable and, hence, less stable walking pattern.
[19]
Lyapunov exponent A non-linear measure that assesses the sensitivity of the system to perturbations in the AP, ML
or VT directions. The Lyapunov exponent provides an indication of the local dynamic stability of
the gait pattern, with lower values representing increased local stability during gait.
[20]
Entropy rate Assesses the regularity of the AP, ML and VT accelerations. Values range from 0, which
represents no regularity (maximum randomness) to 1, which represents maximum regularity.
[20]
Cross entropy rate Non-linear measure of asynchrony between two related time series. Used to assess how well
the pattern of AP acceleration (for example) can predict ML accelerations. Higher values
indicate more synchronisation between the acceleration patterns and, hence, a more stable gait
pattern.
[20]
Width of the dominant
frequency
The width of the dominant harmonic of the power spectral density of the acceleration signal.
Greater widths, represent greater dispersion and greater variability of the gait pattern.
[22,31,35,36]
Relative phase analysis A graphic-based analysis that plots the angular position of a segment against the angular
velocity of the same segment. Relative phase analysis provides a measure of the coordination
between two adjoining segments (e.g. pelvic and trunk) and the overall stability of this pattern.
[29]
Phase coordination index
(PCI)
Stable walking has step times that are approximately half the length of the gait cycle (i.e. 180° of
a 360° cycle). Deviation from this expectation is considered an inaccuracy. The PCI is a
summary measure that combines this value representing the accuracy with the coefﬁcient of
variation, representing consistency, hence the PCI is considered a measure of gait coordination.
[14]
Symmetry index (SIindex) The SIindex compares movements from one side (e.g. injured) to the other side (e.g. uninjured).
Perfect symmetry is represented by zero and larger numbers represent more asymmetry.
[27]
Gait asymmetry (SIGA) Mean swing time is calculated for both left and right legs. Gait asymmetry is the natural log (ln)
of the swing time of the leg with the shortest swing time divided by the swing time of the leg with
the longer swing time. Values closer to zero represent a symmetrical movement pattern.
[27]
Symmetry angle (SIangle) Measures the relationship between discrete values obtained from the left and right side and is
derived when the right-side value is plotted against the left-side value to create a line that forms
an angle with the x-axis. Angles that deviate from 45° represent some degree of asymmetry.
[27]
Maximum angular velocity
ratio (SIratio)
Ratio of the maximum angular velocity of the left leg (averaged over all gait cycles) to maximum
angular velocity of the right leg (averaged over all gait cycles). Values that are closer to zero
represent better symmetry between the left and right sides of the body.
[27]
Trend symmetry (SItrend) Translated data from the left and right sides of the body are used to derive eigenvectors. Trend
symmetry assesses the ratio of the variability about the eigenvector (y-axis) to the variability
along the eigenvector (x-axis). A value of zero represents perfect symmetry.
[27]
LCEA symmetry magnitude
(SILCEA)
Applies a latency corrected ensemble average (LCEA) to assess the correlation between the
magnitudes of the signals collected from the left and right sides of the body using a cross-
correlation approach. Larger values represent a greater degree of symmetry.
[27]
Fractal Brownian Motion Fractal measures provide an indication of the complexity of the AP, ML, VT accelerations during
walking. Higher values represent more complex walking patterns, hence walking patterns that
are more difﬁcult to coordinate and control effectively.
[21]
Vertical Patterns A time-frequency pattern of the energy of the acceleration signal for AP, ML and VT directions.
Vertical patterns represent impulse type activities during the walking cycle.
[34]
Circular Patterns A time-frequency pattern of the energy of the acceleration signal for AP, ML and VT directions.
Circular patterns characterise irregular burst like patterns during the walking cycle.
[34]
Horizontal Patterns A time-frequency pattern of the energy of the acceleration signal for AP, ML and VT directions.
Horizontal patterns represent long-term smooth and regular activities.
[34]
doi:10.1371/journal.pone.0123705.t002
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that issues related to internal and external validity, as well as statistical power are typically poorly
reported in the literature. It should be emphasised that this does not suggest that the authors
did not consider some or all of these factors, but rather suggests that these areas should be given
more attention in the reporting of future research. To improve the overall methodological quality
of research in this area, it is recommended that scientists use existing research reporting guide-
lines (e.g. CONSORT, STROBE) when designing and planning the reporting of their studies.
Despite the outlined shortcomings in the reporting of the methods, 81% of the studies de-
scribed differences between different PD groups and/or a healthy control group for one or more
of their sensor-based measures of standing balance or walking stability [13, 14, 17–22, 25–27,
29–37, 39, 40]. However, contradictory findings reported in separate studies suggest that some
of the reported outcomes may be more robust than others. For example, two studies that com-
pared PD patients with controls using a standing balance assessment reported no significant
differences between the groups for jerk scores [37, 38], while three others reported significantly
greater jerk scores for PD patients [13, 25, 26]. Similarly, two studies reported no differences be-
tween people with PD and controls for RMS accelerations [24, 38], while three studies reported
significantly greater RMS accelerations for PD patients [13, 25, 26]. Sway velocity was another
common measure used to evaluate standing balance, but similarly only three studies [25, 26, 33]
reported differences between people with PD and controls, while the remaining three did not
[13, 32, 38]. It is interesting to note, however, that contradictory findings were presented by the
three studies reporting differences between patients and controls for sway velocity, as one study
reported reduced values for PD patients while standing with eyes closed [33], while the others
reported greater values for people with PD while standing with eyes open [25, 26], but not eyes
closed [26]. While each of the studies that assessed standing balance derived their outcomes
from a wearable sensor positioned on the trunk [13, 24–26, 32, 33, 37, 38], there were some
methodological differences that may explain the discrepancies observed between the studies’ re-
ported outcomes. The studies unable to report significant differences in jerk scores, RMS accel-
erations and sway velocities assessed standing balance using a semi-tandem stance test [38], the
Sensory Organisation Test [24], the Romberg test [32] or an instrumented version of the func-
tional reach test [37]. In contrast, the studies that reported significant differences for jerk, RMS
accelerations and sway velocities assessed participants during quiet standing with the heels sepa-
rated by 10 cm [13, 25, 26] or while they stood with their feet together or in a semi-tandem
stance with their eyes open and closed [33]. Given the available evidence, it seems that the best
recommendation for clinicians seeking to assess standing balance using wearable sensors would
be to calculate RMS accelerations or jerk scores from trunk accelerations collected while patients
stand with their eyes open and their heels 10 cm apart. However, a degree of caution may be re-
quired when considering this recommendation, as three of the four studies that reported differ-
ences in standing balance for people with PD appear to have used the same patient cohort, due
to the reported demographics being the same for each study [13, 25, 26]. As such, it is possible
that the overall interpretation of the existing literature in this area may be biased and the trans-
ferability of the findings may be more limited than they appear.
In addition to the nine studies that used wearable sensors to assess standing balance, the
remaining 65% used these devices to assess walking stability. These studies reported numer-
ous outcome measures derived from the acceleration signals, but the Harmonic Ratio (HR)
was the most commonly-reported measure and was calculated for the head [30] and lumbo-
sacral region [14, 17, 19, 20, 30, 31, 35, 39]. The HR seems to be a sensitive and versatile mea-
sure of walking stability, as the reviewed literature reports differences between people with
PD and controls [14, 19, 20, 30], PD freezers and non-freezers [35], PD fallers and non-fallers
[30, 31], PD patients with different dominant symptoms [17] and different methods of cueing
for people with PD [39]. Stride timing variability was the second most common outcome
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measure for the studies that assessed walking stability, but careful review of the included
studies suggested that it may not be a dependable measure for discriminating between differ-
ent populations. Of the seven studies that reported this outcome, three described differences
in stride timing variability between PD fallers and non-fallers [30], PD patients and controls
[22, 30] or carriers and non-carriers of the LRRK2 gene mutation [36]. In contrast, four stud-
ies reported no differences between PD patients and controls [19, 28, 29] or patients with dif-
ferent sub-types of PD [17]. A common characteristic of those studies reporting differences
for the HR and stride timing variability was that they each assessed walking stability during
straight line walking. As such, it is recommended that clinicians who wish to assess walking
stability using wearable sensors calculate the HR from trunk accelerations collected while pa-
tients walk in a straight line at a self-selected speed. While there is some evidence to support
the use of stride timing variability to assess walking stability, it would only be recommended
as a secondary measure due to the inconsistencies evident within the current literature.
While it was not the primary focus of this review to evaluate the effects of anti-parkinsonian
medications, such as levodopa, on measures of standing balance and walking stability, it is an im-
portant factor that warrants consideration. It is widely recognised that levodopa improves symp-
toms of PD (based on the UPDRS) [17, 32], spatiotemporal gait characteristics (e.g. stride length)
[52, 53] and performance on clinical tests of balance, such as the Berg Balance scale [54]. Of the
studies included in this review, five (19%) reported assessing standing balance or walking stability
while patients were not medicated [14, 24, 33, 38, 40], 9 (35%) assessed patients on-medication
[18–21, 30, 31, 35, 36, 39] and three (12%) assessed patients in both on and off states [17, 22, 32].
Of the remaining studies, six (22%) assessed patients who were not yet being medicated for PD
[13, 25–29], while three (12%) did not report whether their participants were on or off medica-
tion at the time of testing [23, 34, 37]. Interestingly, of the studies not reporting differences in
standing balance or walking stability between different groups of PD patients and/or healthy con-
trols, two assessed patients while they were off medication [24, 38], while the other did not report
whether patients were assessed on or off medication [23]. Of the three studies that assessed pa-
tients on and off medication, only two statistically compared their presented outcomes for the
two conditions [22, 32]. For a group of idiopathic PD patients, it was reported that the length
and maximal distance of postural sway was significantly increased during normal stance, when
patients were assessed on medication [32], which would typically be interpreted as a greater
amount of sway during the medicated state. During walking, Weiss et al. [22] reported a signifi-
cant reduction in the width of the dominant harmonic in the acceleration signal when patients
were tested on medication, which represented less variability in the gait patterns of medicated pa-
tients. While there is a clear need for further research in this area, the presented findings suggest
that wearable sensors can be effectively used to evaluate changes in standing balance and walking
stability for different patients who are assessed with or without anti-parkinsonian medication.
Considering that 66% of individuals with PD fall at least once in a given year [11, 55] and
nearly 50% of these falls occur during locomotion [56, 57], assessing walking stability and falls
risk is critical to ensure that high-risk patients can be easily identified by clinicians. However,
to date, there is a paucity of research evaluating the capacity for wearable sensors to identify
people with PD who are at a higher risk of prospectively falling. Two of the studies included in
this review compared people with PD who retrospectively reported having no falls (non-fall-
ers) to those who reported falling at least once (fallers) in the previous 12 months [30, 31].
Both of these studies reported that PD fallers had less rhythmic movements for the pelvis or
lower trunk (as assessed using the HR) in both the anterior-posterior (forward-backward) and
vertical directions compared with PD non-fallers [30, 31] and controls [30]. While their retro-
spective nature makes it difficult to determine whether these deficits contribute to the patients
falling or whether they are perhaps a consequence of an increased fear of future falls, the
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results of these studies provide some support for the use of wearable sensors for screening pa-
tients for falls risk. Nevertheless, further prospective research is needed to confirm whether
sensor-based measures of standing balance or walking stability are suitable for the assessing
falls risk and predicting future falls in this population.
There are a number of limitations that should be considered when interpreting the results of
this review of literature. First, the results of the methodological quality assessment included in this
systematic review are based on the assessor’s (RPH) interpretation of each of the studies. Often, the
results reflect the quality of the reporting of the research and, hence, should not be seen as a critique
of the significance of the research and its outcomes. Second, given the relatively small number of
studies published in this area and the wide variety of research questions addressed using wearable
sensors, it is difficult to make strong recommendations regarding the most appropriate equipment,
placements and outcomes for assessing standing balance and walking stability in people with PD.
In light of these limitations, the results presented in this systematic review should be considered
preliminary and additional work will be required as this field of science continues to evolve.
In conclusion, wearable sensors provide a light-weight, portable and affordable alternative
to more expensive three-dimensional motion analysis systems and are effective for detecting
changes in standing balance and walking stability among people with PD. However, it appears
that some outcome measures may be more useful than others for discriminating patient co-
horts from controls. Specifically, measures of jerk and RMS acceleration for the trunk appear
to be the best sensor-based measures of standing balance, even under less challenging condi-
tions (i.e. feet apart on a firm surface with eyes open). For assessments of walking stability, a
trunk-mounted wearable sensor can be used to assess the rhythmicity of dynamic gait patterns
using the HR calculated for the three axes of motion. While some studies have provided sup-
port for other more complex frequency-based measures of postural stability, additional re-
search is essential to objectively assess the utility of these measures for the PD population.
Future research should give careful consideration to the internal and external validity of their
methods and provide an appropriate sample size calculation to support their study, as these as-
pects could have been better reported in the existing literature.
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